SARS Nucleocapsid Protein Antibody Summary
Immunogen |
The antibody was developed by immunizing Rabbit with a synthetic peptide corresponding to amino acids 84-99 (C-IGYYRRATRRIRGGDG) from the N (SARS Nucleocapsid) for the Human SARS coronavirus (Genbank accession no. YP_009724397.2) |
Predicted Species |
SARS-CoV-2 (94%). Backed by our 100% Guarantee. |
Isotype |
IgG |
Clonality |
Polyclonal |
Host |
Rabbit |
Gene |
N |
Purity |
Protein A purified |
Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
Dilutions |
- ELISA 1:100-1:2000
- Western Blot 1:100-1:2000
|
Application Notes |
The antibody was tested on a cell line transfected with full-length SARS Nucleocapsid cDNA with a predicted molecular weight of 46 kDa. |
Publications |
|
Reactivity Notes
Immunogen displays the following percentage of sequence identity for non-tested species: COVID-19 (94%)
Packaging, Storage & Formulations
Storage |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Buffer |
PBS |
Preservative |
0.05% Sodium Azide |
Concentration |
1.0 mg/ml |
Purity |
Protein A purified |
Alternate Names for SARS Nucleocapsid Protein Antibody
Background
It has recently been shown that SARS is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness in humans, such as the common cold. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The first step in coronavirus infection is binding of the viral spike protein, a 139-kDa protein, to certain receptors on host cells. The spike protein is the main surface antigen of the coronavirus. The most prominent protein in the culture supernatants infected with SARS virus is a 46 kDa nucleocapsid protein. This suggests that the nucleocapsid protein is a major immunogen that may be useful for early diagnostics.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Publications for SARS Nucleocapsid Protein Antibody (NB100-56049)(3)
Showing Publications 1 -
3 of 3.
Publications using NB100-56049 |
Applications |
Species |
Cameron A, Porterfield CA, Byron LD et al. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization Journal of Clinical Microbiology 2021-01-21 [PMID: 33139422] |
|
|
Zhang L, Wei L, Jiang D et al. SARS-CoV nucleocapsid protein induced apoptosis of COS-1 mediated by the mitochondrial pathway. Artif Cells Blood Substit Immobil Biotechnol. 2007-01-01 [PMID: 17453707]
Details: WB: Fig. 1 (COS-1, Huh-7, and Hep2 transiently or mock-transfected with SARS Matrix, Spike, or Nucleocapsid proteins), Antibodies were transfected validated. Imgenex products cited: 1. SARS-Spike (IMG-5119A) 2. SARS-Spike (IMG-5015) 3. SARS-M (IMG-5125A). |
|
|
Ren Lili, Yang Renquan, Guo Li et al. Apoptosis induced by the SARS-associated coronavirus in Vero cells is replication-dependent and involves caspase. DNA Cell Biol. 2005-08-01 [PMID: 16101347] |
|
|
Reviews for SARS Nucleocapsid Protein Antibody (NB100-56049) (0)
There are no reviews for SARS Nucleocapsid Protein Antibody (NB100-56049).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
Video Protocols
FAQs for SARS Nucleocapsid Protein Antibody (NB100-56049) (0)
Secondary Antibodies
| |
Isotype Controls
|
Additional SARS Nucleocapsid Protein Products
Blogs on SARS Nucleocapsid Protein